Literature DB >> 2089835

A nationwide survey of antibiotic prescribing patterns and clinical outcomes in patients with bacterial pneumonia.

T H Grasela1, L S Welage, C A Walawander, E G Timm, M A Pelter, T I Poirier, J K Walters.   

Abstract

Antibiotic prescribing information was prospectively collected on 1822 hospitalized patients treated for suspected or documented bacterial pneumonia. Antibacterial therapy with a single antibiotic was employed in more than 50 percent of the patients, with cefazolin, cefuroxime, ampicillin, and ceftriaxone sodium representing the most commonly employed agents. Combination therapy using two antibiotics was employed in approximately 30 percent of patients with the aminoglycosides, particularly gentamicin, used extensively. A satisfactory outcome was achieved in approximately 80 percent of patients with a community- or institutional-acquired pneumonia; only 66 percent of nosocomial pneumonias had a satisfactory outcome. An important observation was the apparently common practice of switching patients to an oral antibiotic regimen after an average of seven days of antibiotics and subsequently discharging the patient. No difference was observed in the patterns of clinical response or duration of therapy for culture-positive versus culture-negative patients. The results of this surveillance program can serve as a basis for comparison of institution-specific drug utilization evaluation programs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2089835     DOI: 10.1177/106002809002401215

Source DB:  PubMed          Journal:  DICP        ISSN: 1042-9611


  6 in total

1.  Reasons for choice of antibiotic for the empirical treatment of CAP by Canadian infectious disease physicians.

Authors:  J Pendergrast; T Marrie
Journal:  Can J Infect Dis       Date:  1999-09

Review 2.  Drug treatment of pneumonia in the elderly: efficacy and costs.

Authors:  E Saltiel; S Weingarten
Journal:  Pharmacoeconomics       Date:  1993-04       Impact factor: 4.981

3.  Cost-effectiveness opportunities for new antibiotics.

Authors:  A Hillman
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

Review 4.  When does 2 plus 2 equal 5? A review of antimicrobial synergy testing.

Authors:  Christopher D Doern
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

Review 5.  Combination therapy for treatment of infections with gram-negative bacteria.

Authors:  Pranita D Tamma; Sara E Cosgrove; Lisa L Maragakis
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 6.  Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials.

Authors:  Mical Paul; Ishay Benuri-Silbiger; Karla Soares-Weiser; Leonard Leibovici
Journal:  BMJ       Date:  2004-03-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.